Trinidad and Tobago vs Vanuatu: Prevalence rate of hypertension in women aged 30-79
Trinidad and Tobago
41.6
in 2019
Vanuatu
41.8
in 2019
Trinidad and Tobago rank
56th
Vanuatu rank
53rd
Prevalence rate of hypertension in women aged 30-79 over time
- Trinidad and Tobago
- Vanuatu
How they compare
Vanuatu currently reports 41.8 against 41.6 in Trinidad and Tobago, a difference of 0.2.
Across all 30 years both countries report, Vanuatu has been ahead every year.
Trinidad and Tobago ranks 56th and Vanuatu ranks 53rd of 195 countries.
Vanuatu has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.61 | 34.95 | 1.34 | Vanuatu |
| 2000s | 36.12 | 37.13 | 1.01 | Vanuatu |
| 2010s | 40.29 | 40.48 | 0.19 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Trinidad and Tobago or Vanuatu?
- Vanuatu, at 41.8 against 41.6 in Trinidad and Tobago as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Trinidad and Tobago and Vanuatu?
- 0.2, with Vanuatu ahead.
- How many years of comparable data are there for Trinidad and Tobago and Vanuatu?
- 30 years are reported by both, from 1990 to 2019.
- How do Trinidad and Tobago and Vanuatu rank globally for prevalence rate of hypertension in women aged 30-79?
- Trinidad and Tobago ranks 56th and Vanuatu ranks 53rd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.